Evidence map›Paper›PMID 31148964›Full record

ArticleAfrican health sciences2019

Glyceryl trinitrate blocks staphyloxanthin and biofilm formation in

Hisham A Abbas, Ahmed M Elsherbini, Moutaz A Shaldam

Open access · diamondAbstract read
In one paragraph

Article in African health sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Synergistic Antibacterial Effect of Ethyl Acetate Fraction ofAdvances in pharmacological and pharmaceutical sciences · 2023
    Article
  5. Article
  6. Article
  7. The promising anti-virulence activity of candesartan, domperidone, and miconazole on Staphylococcus aureus.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Genome-Wide Analysis ofFrontiers in microbiology · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Hisham A AbbasDepartment of Microbiology and Immunology-Faculty of Pharmacy-Zagazig University-Zagazig-Egypt.
Ahmed M ElsherbiniHealth Sciences College-Umm Al Qura University, AlQunfudah, Saudi Arabia.
Moutaz A ShaldamDepartment of Medicinal Chemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.
Delta University for Science and Technology · EGUmm al-Qura University · SAZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

objectivesInvestigation of the ability of glyceryl trinitrate (GTN) to inhibit staphyloxanthin, biofilm and tolerance to oxidative stress.

methodsThe disk sensitivity method was used to detect the methicillin resistance of

resultsGTN showed a significant inhibition of biofilm, staphyloxanthin and tolerance to oxidative stress. In the molecular docking study, it was found that GTN could bind to dehydrosqualene synthase enzyme by hydrogen bonding, electrostatic interaction and pi-cation interaction.

conclusionThe present study revealed the ability of GTN to serve as a potential anti-virulence candidate for attenuation of

Indexed as

BiofilmsDrug Resistance, MicrobialHumansMolecular Docking SimulationNitroglycerinOxidative StressStaphylococcal InfectionsStaphylococcus aureusVirulenceVirulence FactorsXanthophyllsNitroglycerinstaphyloxanthinVirulence FactorsXanthophyllsbiofilmGlyceryl trinitrateStaphylococcus aureusstaphyloxanthin

Identifiers

PMID31148964
PMCPMC6531949
OpenAlexW2942412563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.